+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cellular Health Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 184 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804659

Global Cellular Health Testing Market to Reach $5.8 Billion by 2030

The global market for Cellular Health Testing estimated at US$3.3 Billion in the year 2023, is projected to reach a revised size of US$5.8 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Single-Test Panels, one of the segments analyzed in the report, is expected to record 6.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Multi-Test Panels segment is estimated at 8.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $978 Million, While China is Forecast to Grow at 6.9% CAGR

The Cellular Health Testing market in the U.S. is estimated at US$978 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 6.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Report Features

  • Full access to influencer engagement stats
  • Access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 22 Featured) -

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc. (Repeat Dx)
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc. (Tdx)
  • Zimetry LLC

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Cellular Health Testing - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Cellular Health Testing - Revolutionary Technology Provides Overview of Health at Cellular Level
  • North America Projected to Retain Maximum Share in the Market
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Accurate Telomere Length Test Steers Market Growth
  • Digital Transformation in Healthcare to Offer Significant Market Gains
  • Focus on Healthy Life Expectancy (HLE) as a Measure of Population Health Promise Growth Opportunities
  • Cellular Approach to Tackle Chronic Diseases Ensure Steady Growth Prospects
  • Continuous Rise in Geriatric Population Throws Focus on Cellular Heath Screening
  • Percentage (In %) of Global Population Aged 65 and Above by Region
  • US Population (In Million) Aged 65 and Above for the Years 2018, 2021, 2024, 2027, and 2030
  • Government Policies and Measures Promoting Preventative Healthcare Augurs Well
  • Personalized and Precision Medicine Presents Application Opportunities for Cellular Health Screening
  • Global Precision Medicine Market (In US$ Billion) for the Years 2019, 2021, 2023, 2025 & 2027
  • Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand
  • Key Challenges
  • Limited Reimbursement
  • Challenges in Sample Transportation
  • Variation in Pricing of Test Kits
  • COVID-19 Impact on Cellular Health Testing Market
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Single-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Multi-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for At-home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for In-office by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Cellular Health Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Other Collection Sites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 29: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: USA Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: USA 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: USA Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: USA 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Canada 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Canada 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 41: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Canada 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
JAPAN
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 44: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Japan 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 47: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Japan 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 50: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Japan Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Japan 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
CHINA
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 53: China Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: China Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: China 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 56: China Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: China Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: China 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 59: China Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: China Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: China 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
EUROPE
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 62: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Europe 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 65: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 68: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 71: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
FRANCE
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 74: France Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: France Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: France 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 77: France Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: France Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: France 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 80: France Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: France Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: France 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
GERMANY
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 83: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Germany Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Germany 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 86: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Germany Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Germany 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 89: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Germany Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Germany 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
ITALY
  • Table 92: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Italy Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Italy 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 95: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Italy Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Italy 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 98: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: Italy Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Italy 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 101: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: UK Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: UK 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 104: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 105: UK Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 106: UK 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 107: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 108: UK Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 109: UK 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 110: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 111: Rest of Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 112: Rest of Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 113: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 114: Rest of Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 115: Rest of Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 116: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 117: Rest of Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 118: Rest of Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 119: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 120: Asia-Pacific Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 121: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
  • Table 122: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 123: Asia-Pacific Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 124: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
  • Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 126: Asia-Pacific Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 127: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc. (Repeat Dx)
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc. (Tdx)
  • Zimetry LLC

Table Information